Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control

<p>T cell responses are crucial in viral clearance, but little is known of the role of cytotoxic CD4+ T cells in the control of viral infection. </p> <p>Chronic hepatitis B virus (HBV) infection is a global public health problem. In the first part of my study, HBx-specific T cell...

Detaylı Bibliyografya
Yazar:	Liu, G
Diğer Yazarlar:	Dong, T
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	2023
Konular:	Infection Immunology

Benzer Materyaller

Computational Investigation of Selected Spike Protein Mutations in SARS-CoV-2: Delta, Omicron, and Some Circulating Subvariants
Yazar:: Urmi Roy
Baskı/Yayın Bilgisi: (2023-12-01)

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity
Yazar:: Dong Sun Oh, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
Yazar:: Xiao-Lin Jiang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Anti-SARS-CoV-2 antibodies in a nasal spray efficiently block viral transmission between ferrets
Yazar:: Kiira Gildemann, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Characterising the T cell responses to SARS-CoV-2 including variants of concern induced by natural infection and vaccines
Yazar:: Adele, S
Baskı/Yayın Bilgisi: (2024)

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Yazar:: Willett, BJ, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
Yazar:: Jay, C
Baskı/Yayın Bilgisi: (2023)

Nonhuman primate antigenic cartography of SARS-CoV-2
Yazar:: Annika Rössler, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
Yazar:: Banghui Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
Yazar:: Sung-Gwon Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies
Yazar:: Olubukola M. Abiona, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
Yazar:: Barton, MI
Baskı/Yayın Bilgisi: (2022)

Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
Yazar:: Liu, C
Baskı/Yayın Bilgisi: (2024)

SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
Yazar:: Alba Escalera, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
Yazar:: Mohamed I.M. Ahmed, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Convergence of SARS-CoV-2 spike antibody levels to a population immune setpointResearch in context
Yazar:: Eric J. Nilles, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
Yazar:: Lu Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
Yazar:: Cyril Planchais, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Yazar:: Jeewandara, C, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches
Yazar:: Cena Aram, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
Yazar:: Elizabeth J. Martinez, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Elucidating factors of heterogeneous immune response to SARS-CoV-2 and human immunodeficiency virus
Yazar:: Lim, N
Baskı/Yayın Bilgisi: (2024)

SARS-CoV-2 spike S2-specific neutralizing antibodies
Yazar:: Chia-Jung Li, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

SARS-CoV-2 vaccine development and challenges
Yazar:: Duan Fugang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Yazar:: Carter, Brandon, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation
Yazar:: Yuanling Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
Yazar:: Sarah E. Cummings, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity
Yazar:: MST Monira Begum, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Examining the immunoreactivities of the receptor-binding domain of SARS-CoV-2 spike proteins using a panel of human monoclonal antibodies
Yazar:: Tan, Jie Ling
Baskı/Yayın Bilgisi: (2022)

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
Yazar:: Alexander Muik, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies
Yazar:: Antonio Giordano, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
Yazar:: Samuele Notarbartolo
Baskı/Yayın Bilgisi: (2024-09-01)

Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies
Yazar:: A. A. Derkaev, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
Yazar:: Rajesh Rajaiah, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies
Yazar:: Youngchang Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection
Yazar:: Eleonora Vecchio, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

The impact of HLA-driven escape mutation on viral replicative capacity and immune control in HIV infection
Yazar:: Tsai, M
Baskı/Yayın Bilgisi: (2017)

Design and characterization of therapeutic peptides targeting the receptor binding domain of the spike glycoprotein from sars-cov-2
Yazar:: Ho, Chian
Baskı/Yayın Bilgisi: (2023)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
Yazar:: Masayuki Aboshi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Direct activation of airway sensory C‐fibers by SARS‐CoV‐2 S1 spike protein
Yazar:: Joyce S. Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)